These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18767046)

  • 41. Pap smears. Still a reliable screening tool for cervical cancer.
    Stack PS
    Postgrad Med; 1997 Apr; 101(4):207-8, 211-4. PubMed ID: 9126213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program.
    Thipsanthiah K; Kamsa-Ard S; Musika W; Teemuangsai W; Hawlader MDH
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3429-3436. PubMed ID: 37898847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
    Mitchell H; Hocking J; Saville M
    Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for cervical cancer by Pap smear.
    Rizvi JH; Hasan S; Rasul S; Ghazali B; Jamal A
    J Pak Med Assoc; 1988 Sep; 38(9):229-31. PubMed ID: 3149319
    [No Abstract]   [Full Text] [Related]  

  • 46. Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study.
    Lindau ST; Basu A; Leitsch SA
    J Gen Intern Med; 2006 Aug; 21(8):829-34. PubMed ID: 16881942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Probability of early repeat Pap smear in an integrated cervical screening programme.
    Rosso A; Foglietta F; Naldoni C; Schincaglia P; Buzzi G; Camprincoli S; Serafini M; Busoli S; Leoni F; Grilli N; Bucchi L
    Eur J Cancer Prev; 2000 Aug; 9(4):269-74. PubMed ID: 10958330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smear misclassification in a cervical cancer screening programme.
    Lynge E; Arffmann E; Poll P; Anderson PK
    Br J Cancer; 1993 Aug; 68(2):368-73. PubMed ID: 8347493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of cytology with Pap smears taken by a gynecologist and with a self-sampling device.
    Pengsaa P; Sriamporn S; Kritpetcharat O; Kamsa-Ard S; Suwanrungruang K; Noda S; Kakudo K
    Asian Pac J Cancer Prev; 2003; 4(2):99-102. PubMed ID: 12875620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for cervical cancer in an African setting.
    Cronjé HS; Beyer E
    Int J Gynaecol Obstet; 2007 Aug; 98(2):168-71. PubMed ID: 17585915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
    van Oortmarssen GJ; Habbema JD
    Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
    Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
    Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consequences of current patterns of Pap smear and colposcopy use.
    Kavanagh AM; Santow G; Mitchell H
    J Med Screen; 1996; 3(1):29-34. PubMed ID: 8861048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Merits and pitfalls of normal saline rehydrated air-dried cervical smears over conventional wet.fixed PAP smears: A comparative study.
    Kamble SA; Dombale VD; Shah F
    Indian J Pathol Microbiol; 2022; 65(1):100-104. PubMed ID: 35074972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Is there a benefit to continue pap smear screening for cervical cancer after 65 years of age? A retrospective study on 53,644 women].
    Meyer R; Lemay AL; Guy X; Giraud C; Mathevet P; Flori M
    Bull Cancer; 2012 Apr; 99(4):409-15. PubMed ID: 22450525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening practices and invasive cervical cancer risk in different age strata.
    Parazzini F; Negri E; La Vecchia C; Bocciolone L
    Gynecol Oncol; 1990 Jul; 38(1):76-80. PubMed ID: 2354830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cervical Cancer Screening: Recommendations for Muslim Societies.
    Khodakarami N; Farzaneh F; Yavari P; Akbari ME
    Asian Pac J Cancer Prev; 2016; 17(1):239-47. PubMed ID: 26838217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time to clinical investigation for Indigenous and non-Indigenous Queensland women after a high grade abnormal Pap smear, 2000-2009.
    Whop LJ; Baade PD; Brotherton JM; Canfell K; Cunningham J; Gertig D; Lokuge K; Garvey G; Moore SP; Diaz A; O'Connell DL; Valery P; Roder DM; Condon JR
    Med J Aust; 2017 Feb; 206(2):73-77. PubMed ID: 28152354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
    Schneider V
    Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.